Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria M Villaflor

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Complexity of Delivering Precision Medicine: Opportunities and ChallengesAndrew A Davis, Amy E McKee, Warren A Kibbe, et al.
The Oncologist|August 11, 2021
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of CasesRanjan Pathak, Anjan Katel, Erminia Massarelli, et al.
Head & Neck|January 11, 2020
Survivorship support in head and neck cancer: American Head and Neck Society surveyDavid M Cognetti, Victoria M Villaflor, Carole Fakhry, et al.
Cancers|January 9, 2021
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of FailureRanjan Pathak, Rebecca R Pharaon, Atish Mohanty, et al.
World Journal of Gastroenterology|December 15, 2012
Multidisciplinary approach for patients with esophageal cancerVictoria M Villaflor, Marco E Allaix, Bruce Minsky, et al.
Current Treatment Options in Oncology|May 5, 2023
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?Juan Jose Juarez-Vignon Whaley, Michelle Afkhami, Sagus Sampath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
Journal of Clinical Medicine|June 28, 2023
Building Team Medicine in the Management of CNS MetastasesArchit B Baskaran, Robin A Buerki, Osaama H Khan, et al.
Clinical Lung Cancer|September 9, 2020
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint InhibitorsMichael S Oh, Alex Guzner, Derek A Wainwright, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Complexity of Delivering Precision Medicine: Opportunities and ChallengesAndrew A Davis, Amy E McKee, Warren A Kibbe, et al.
The Oncologist|August 11, 2021
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of CasesRanjan Pathak, Anjan Katel, Erminia Massarelli, et al.
Head & Neck|January 11, 2020
Survivorship support in head and neck cancer: American Head and Neck Society surveyDavid M Cognetti, Victoria M Villaflor, Carole Fakhry, et al.
Cancers|January 9, 2021
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of FailureRanjan Pathak, Rebecca R Pharaon, Atish Mohanty, et al.
World Journal of Gastroenterology|December 15, 2012
Multidisciplinary approach for patients with esophageal cancerVictoria M Villaflor, Marco E Allaix, Bruce Minsky, et al.
Current Treatment Options in Oncology|May 5, 2023
Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?Juan Jose Juarez-Vignon Whaley, Michelle Afkhami, Sagus Sampath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2013
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologistsRena M Conti, Arielle C Bernstein, Victoria M Villaflor, et al.
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
Journal of Clinical Medicine|June 28, 2023
Building Team Medicine in the Management of CNS MetastasesArchit B Baskaran, Robin A Buerki, Osaama H Khan, et al.
Clinical Lung Cancer|September 9, 2020
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint InhibitorsMichael S Oh, Alex Guzner, Derek A Wainwright, et al.
Pageof 5